Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Hoare

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomniaKarine Lavrador-Erb, Satheesh Babu Ravula, Jinghua Yu, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2011
Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6Charles Huang, Wilna J Moree, Said Zamani-Kord, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated miceJoseph Pontillo, Joseph A Tran, Stacy Markison, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H₁-antihistamines for insomniaSatheesh Babu Ravula, Jinghua Yu, Joe A Tran, et al.
Bioorganic & Medicinal Chemistry Letters|March 16, 2010
Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomniaBin-Feng Li, Wilna J Moree, Jinghua Yu, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic propertiesJohn E Tellew, Marion Lanier, Manisha Moorjani, et al.
Pharmacological Research|November 8, 2025
Kinetic multiplex assay to assess biased signaling of clinical GPCR agonistsJara Bouma, Elisa J M de Koning, Cas van der Horst, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Novel benzothiophene H1-antihistamines for the treatment of insomniaWilna J Moree, Florence Jovic, Timothy Coon, et al.
Journal of Medicinal Chemistry|September 2, 2005
Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonistsRaymond S Gross, Zhiqiang Guo, Brian Dyck, et al.
Journal of Medicinal Chemistry|August 12, 2009
Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomniaWilna J Moree, Bin-Feng Li, Florence Jovic, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomniaKarine Lavrador-Erb, Satheesh Babu Ravula, Jinghua Yu, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2011
Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6Charles Huang, Wilna J Moree, Said Zamani-Kord, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated miceJoseph Pontillo, Joseph A Tran, Stacy Markison, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H₁-antihistamines for insomniaSatheesh Babu Ravula, Jinghua Yu, Joe A Tran, et al.
Bioorganic & Medicinal Chemistry Letters|March 16, 2010
Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomniaBin-Feng Li, Wilna J Moree, Jinghua Yu, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic propertiesJohn E Tellew, Marion Lanier, Manisha Moorjani, et al.
Pharmacological Research|November 8, 2025
Kinetic multiplex assay to assess biased signaling of clinical GPCR agonistsJara Bouma, Elisa J M de Koning, Cas van der Horst, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Novel benzothiophene H1-antihistamines for the treatment of insomniaWilna J Moree, Florence Jovic, Timothy Coon, et al.
Journal of Medicinal Chemistry|September 2, 2005
Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonistsRaymond S Gross, Zhiqiang Guo, Brian Dyck, et al.
Journal of Medicinal Chemistry|August 12, 2009
Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomniaWilna J Moree, Bin-Feng Li, Florence Jovic, et al.
Pageof 8